FDA's Dexcom page turns Monday's device-safety warning into two specific G7 lot numbers, 1725204004 and 1725069002, and the distinction matters because the agency says the stolen scrap products from lot 1725204004 had not undergone required sterilization, creating possible skin-infection risk. [1]

Products from lot 1725069002 may provide no sensor reading, which could affect glucose monitoring decisions, so the two lots describe different hazards rather than one generic device scare. [1]

FDA also narrows the distribution warning by saying the issue primarily affects the United States, authorized Dexcom distributors are not impacted, Pharmsource is not an authorized distributor, and users should not use affected sensors but should call 1-844-478-1600. [1]

That is the useful version of a black-market medical-device story: the argument on X will be about trust in devices, while the patient task is to check the lot, check the seller, and avoid using a sensor FDA says came from stolen scrap.

The authorized-distributor line is not corporate decoration, because continuous glucose monitors guide daily insulin decisions, a bad reading and no reading are both practical hazards, and FDA's notice asks users not to abandon the system but to remove two named lots from the daily decision chain and route questions through Dexcom's listed phone number.

-- NORA WHITFIELD, Chicago